Meta-analysis of 15 studies demonstrated that the combination of GLP-1 RA and basal insulin, in comparison with other anti-diabetic treatments, can enable achievement of robust glycemic control, without increased risk of hypoglycemia and weight gain [7]. Here, GLP1R is linked to Hypoglycemia.